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ABSTRACT 
The use of traditional medicine for treating human diseases remain widespread in low-resource 
settings. Medicinal plants form the backbone for traditional medicine systems in many parts of 
the world. In Uganda, most communities rely on medicinal plants to prevent and treat oral 
diseases. Despite the long history and widespread use of these plants in oral health care, there 
is limited scientific evidence on the efficacy and safety of these plants. The aim of this thesis 
was to investigate various extracts from the medicinal plants for anti-bacterial, cytotoxic and 
potential anti-inflammatory effects. 
 
The thesis is based on three studies. Study 1 investigated 16 commonly used plant species from 
different parts of Uganda. Pulp juice from fresh plant materials and solvent extracts (hexane, 
methanol and water) from dry plant materials were obtained and tested for their anti-bacterial 
effects on periodontopathic bacteria Aggregatibacter actinomycetemcomitans, 
Porphyromonas gingivalis, Tannerella forsythia and cariogenic bacteria Streptococcus mutans, 
Streptococcus sobrinus, Lactobacillus acidophilus. Study II assessed the essential oil extracts 
from ten Ugandan aromatic medicinal plants for growth inhibitory effects on periodontopathic 
bacteria A. actinomycetemcomitans, P. gingivalis, and cariogenic bacteria S. mutans and L. 
acidophilus. Chemical compositions of the oils were explored by gas chromatography–mass 
spectrometry. Study III investigated the cytotoxicity of essential oils from four promising 
plants (Bidens pilosa, Ocimum gratissimum, Cymbopogon nardus, Zanthoxylum chalybeum) 
that had shown strong anti-bacterial effects on Gram-negative periodontopathic bacteria A. 
actinomycetemcomitans, P. gingivalis in Study II.  Potential effects of the oils on the production 
of pro-inflammatory cytokines (IL-6, IL-8 and prostaglandin E2) by human gingival fibroblasts 
induced by IL-1β were also investigated. 
 
In study I, the major findings were that fresh pulp juice prepared from Zanthoxylum chalybeum  
and Euclea latidens showed activity against all the bacterial species tested and at all strengths. 
Hexane extract from the aerial part of Helichrysum odoratissimum exhibited the best activity 
with MIC ranging from 0.0125 to 0.5mg/ml on all the bacterial species tested except A. 
actinomycetemcomitans. Methanol extract from Lantana trifolia was active on all the bacteria 
tested with MIC ranging 0.25 to 1mg/ml. In study II, the major findings were that essential oil 
from Cymbopogon nardus exhibited the highest activity with complete growth inhibition of A. 
actinomycetemcomitans, P. gingivalis at all the three concentrations tested, the major 
  
 
constituents in the oil being mainly oxygenated sesquiterpenes. Essential oils extracted from 
Teclea nobilis. Hoslundia opposita, Ocimum gratissimum and Bidens pilosa were also 
considered promising because they showed marked growth inhibitory effects on least 2 
bacterial species. In study III, essential oil from Z. chalybeum was the most cytotoxic while the 
oil from C. nardus the least cytotoxic. Essential oil from O. gratissimum significantly decreased 
baseline and induced secretion of Prostaglandin E2.  
 
We conclude that fresh extracts from the roots of Z. chalybeum and E. latidens had anti-
bacterial effects on the cariogenic and periodontopathic bacteria, confirming the use of chewing 
sticks prepared from these plants as a tool for brushing teeth. The hexane extract from the aerial 
part of H. odoratissimum had strong anti-bacterial effects on cariogenic and periodontopathic 
bacteria, suggesting the potential use of this extract, or isolated active principles, in the 
treatment or prevention of dental caries and periodontal diseases. The marked inhibitory effects 
of the essential oils on periodontopathic bacteria A. actinomycetemcomitans and P. gingivalis 
suggest these oils could be avenues to explore for possible application in treatment of 
periodontal diseases. The essential oil extracted from O. gratissimum demonstrated both anti-
bacterial and anti-inflammatory effects suggesting the oil could be worth exploring for possible 
application in treatment of periodontitis. 
Key words: Medicinal plants, periodontal diseases, dental caries, essential oils, oral pathogens, 
human gingival fibroblast, cytotoxicity, pro-inflammatory cytokines. 
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1 INTRODUCTION  
1.1 General overview 
The use of traditional medicine for treating human diseases remain widespread in many parts 
of the world. World Health Organization (WHO) estimates that approximately 80% of the 
population in low-income countries rely mainly on traditional medicines for their primary 
healthcare (WHO, 2002a). In Uganda, it is estimated that approximately 60% of the 
population depend largely on traditional medicine for their health care needs (WHO, 2002a). 
 
Traditional medicine is also referred to as “alternative medicine,” “complementary medicine” 
or “ethno medicine” (WHO, 2008), and the use of plants (herbs) is a core part of all systems 
of traditional medicine (Kim, 2005). The WHO Congress on Traditional Medicine meeting 
in Beijing in 2008 acknowledged the importance of traditional medicine in the delivery of 
healthcare services especially in low-income regions like Sub-Saharan Africa, and further 
declared that systems of traditional medicine like plants should be further developed based 
on research and innovation (WHO, 2008). And indeed medicinal plants have become the 
focus of intense research, not only to find out whether their traditional uses are supported by 
actual pharmacological effects, but also because plants have proven to be sources of 
biologically active compounds, many of which have been the basis for the development of 
new lead chemicals for pharmaceuticals (Fabricant and Farnsworth, 2001; Wachtel-Galor 
and Benzie, 2011). The existence of a huge market for minimally processed medicinal plant 
materials (herbal preparations) especially in developed countries is also giving impetus to 
this research focus. The herbal preparations in many of these developed countries are 
commonly dispensed as over-the-counter medications and herbal supplements and are now 
very popular and of significance in primary health care (Wachtel-Galor and Benzie, 2011). 
Medicinal plants are used for treatment of a number of conditions, including oral diseases 
(Palombo, 2011). 
 
Oral diseases continue to be a major public health problem worldwide, with dental caries and 
periodontal diseases being among the most common (Marcenes et al., 2013; Petersen et al., 
2005). In spite of the general improvement in the overall health status of the population in 
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developed countries, including oral and dental health, the prevalence of dental caries in 
school aged children is reported to be up to 90%, with the majority of adults also affected 
(Petersen et al., 2005). In Uganda, a recent survey indicate dental caries prevalence of 33.5% 
in children and 66.7% in adults (Kutesa et al., 2015).  A recent review also found that severe 
periodontitis affect 11% of the world population (Kassebaum et al., 2014). In Uganda, the 
severe form of periodontitis is reported to affect 6% of the Ugandan youth (Albandar et al., 
2002). 
 
Whereas most developed countries have tackled the burden of oral diseases through 
establishment of organized oral healthcare systems which offer curative and preventive 
services (Petersen et al., 2005), in low-income countries (including Uganda), however , access 
to curative oral healthcare services is limited because of low investments in oral health 
facilities. Where facilities are available, the high cost of treatment still make it out of reach to 
the majority of people (Ministry of Health, 2009; Muhirwe, 2006). The situation is further 
complicated by limited community-oriented prevention programs. The oral health practitioners 
needed to treat the most common oral conditions are also in short supply and the few available 
prefer to work in urban areas where the population that can afford treatment live. This deprive 
the rural population of even the most basic emergency treatment (Muhirwe, 2006). For a large 
number of the rural population in Uganda, medicinal plants offer the only available treatment 
option for dental and other related ailments. Most of the plants used are species indigenous to 
the region, and these may be gathered from the wild for self-medications, obtained from 
traditional healers or purchased from herb sellers. 
 
The use of medicinal plants for treatment of diseases, including oral, have been practiced by 
many people in Uganda and is still being widely practiced. Information on how a particular 
plant is used and the disease it treats is normally passed on orally from generation to generation. 
This kind of information transmission is bound to distortion or loss whenever a medicine man 
dies without passing it to another person. To prevent such information distortion or loss, a 
survey was carried in Uganda with the main purpose of documenting and keeping permanent 
records of the different medicinal plants that are traditionally used in the treatment of various 
diseases, including oral and dental diseases (Mubiru et al., 1994). That study, however, stopped 
at the documentation and did not go further to test whether the traditional uses of these plants 
are supported by their actual pharmacological effects. There have also been several other 
reports on the use of medicinal plants in the traditional treatment of oral diseases in Uganda 
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(Hamill et al., 2003; Hirt and M'Pia, 2008; Kokwaro, 1993; Odongo et al., 2011), but all with 
limited or no laboratory studies to prove pharmacological effects. This thesis therefore 
emanated as a result of an effort to fill this knowledge gap. With the acceptance of medicinal 
plants as an alternative form of oral health care (Anonymous, 2000; WHO, 2002b) and 
renewed interests in natural products, there was an urgent need to evaluate the efficacy of 
these plants if they are to be utilized to their full potentials.  
 
The main focus of the thesis was the efficacy of the plants in treatment periodontal diseases 
and dental caries. Aspects of cytotoxicity and-inflammatory effects were also investigated 
for promising plants extracts.  
 
We envisaged that demonstration of anti-bacterial effects of fresh plant extracts (pulp juice) 
from some of the plants against bacteria associated with dental caries and periodontal diseases 
would promote the use of these plants as chewing sticks by the community (Study I). 
Demonstration of anti-bacterial effects of solvent and essential oil extracts could acts as leads 
for further development of these extracts into modern dental care products (Study I and II). 
Further, it is now well known that much of the tissue destruction that occur in periodontal 
diseases is as a result of the inflammatory reaction in the gingival tissues which is initiated by 
bacteria or their products. But for long, treatment of periodontal diseases has focused on 
elimination of bacterial infection, with little or no attention given to the inflammatory reaction.  
It is therefore not surprising that most patients do not respond well to such treatment approach, 
as they continue to experience ongoing inflammation, tissue damage, and eventual tooth loss. 
Because of this, current research is now focusing on discovering drugs/compounds that are 
endowed with both anti-bacterial and anti-inflammatory activities for the treatment of 
periodontal diseases (Sreenivasan and Gaffar, 2008). It was against this background that the 
thesis also looked at the anti-inflammatory effects of the extracts with promising activities 
especially on the bacteria implicated in the initiation of periodontal diseases (Study III). 
Demonstration of extracts with both anti-bacterial and anti-inflammatory attributes would be a 
basis for further study and development of these extracts into perio-care products. On the other 
hand, we argued that extracts from some of these plants could be having unfavorable effects 
on the gingival tissues and hence that was the basis for investigating the cytotoxicity of the 
promising extracts (Study III).  Efforts were also made to identity the bioactive molecules in 
some of the extracts (Study II).  
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1.2 Effect of extracts from medicinal plants on oral pathogens.  
Multiple studies from different parts of the world suggest that medicinal plants contain 
substances that promote dental health. Some of these studies have focused on oral bacteria 
implicated in the etiology of dental caries and periodontal diseases.  In the Middle East, where 
the use of chewing sticks or miswak made from the desert plant Salvadora persica (Family: 
Salvadoraceae) is widespread, in vitro studies have shown that aqueous extract prepared from 
S. persica exerts anti-bacterial effects on some cariogenic oral bacteria, such as Streptococcus 
mutans, Streptococcus fecalis, Streptococcus salivarius and Lactobacillus sp. (Al-sieni, 2014; 
Almas, 1999).  It has also been shown that S. persica has strong anti-bacterial effects on Gram-
negative oral bacteria Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis 
which are fundamental in the initiation and progression of periodontal diseases (Sofrata et al., 
2008). Clinical studies comparing the mechanical effect of S. persica miswak and modern tooth 
brushing on plaque removal reported that miswak is as effective as tooth brushing in reducing 
plaque and gingivitis (Al-Otaibi et al., 2003). In addition to its mechanical effect, S. persica 
miswak exerts chemical activity against bacteria and plaque formation (Al-Otaibi et al., 2004). 
Studies have also shown that extracts from S. persica reduced acid production in dental plaque, 
which could reduce development of dental caries. (Sofrata et al., 2007). As a result of these 
scientific evidences, extracts from S. persica are now incorporated into commercial 
preparations of a number of toothpastes worldwide (Chaurasia et al., 2013). Some of the 
commercially available toothpastes produced with S. persica extracts are Sarkan toothpaste 
(UK), QualiMeswak toothpaste (Switzerland), Epident toothpaste (Egypt), Siwak- F toothpaste 
(Indonesia), Fluoroswak, Miswak (Pakistan) and Dentacare Miswak Plus (Saudi Arabia) 
(Chaurasia et al., 2013). 
 
Reports from other regions of the world have also demonstrated the potential of traditional 
medicinal in the control of dental caries and periodontal diseases, although extracts from a 
number of these plants are yet to be developed into meaningful oral care products. In the 
Oriental Asia, powdered leaves of Drosera peltata Smith, a carnivorous plant belonging to the 
family Droseraceae, is used by native people in the treatment of dental caries (Didry et al., 
1998). Chloroform extract of the aerial part of Drosera peltata has been shown to have broad-
spectrum activity against numerous bacteria of the oral cavity, with greatest activity against 
caries associated S. mutans and S. sobrinus and moderate activity against periodontal disease 
associated Prevotella intermedia. The compound Plumbagin was identified as the active 
component of this extract (Didry et al., 1998). A Chinese traditional medicinal plant, Coptidis 
 5 
 
Rhizoma (family: Ranunculaceae), is used in treatment of many diseases, including toothache 
(WHO, 1999). A boiling water extract of Coptidis rhizoma was shown to have marked 
inhibitory effects on the growth of periodontopathic bacteria Actinomyces naeslundii, P. 
gingivalis, P. intermedia, Prevotella nigrescens, A. actinomycetemcomitans (MIC: 0.031-0.25 
mg/ml) and less effects on all tested strains of cariogenic bacteria Streptococcus and 
Lactobacillus (MIC: 0.5-2 mg/ml), thus suggesting the potential of its clinical application in 
treatment of periodontal diseases (Hu et al., 2000). In the Mediterranean region, the plant 
Helichrysum italicum (Roth) G. Don fil. (Family: Asteraceae) has been used for its medicinal 
properties for a long time. The plant has many traditional uses including treatment of toothache 
(Viegas et al., 2014)  An ethanol extract  from this plant was found to exert anti-bacterial effects 
on cariogenic S. mutans, S. sanguis and S. sobrinus, with MIC values of 31.25–62.5 μgmL−1 
(Nostro et al., 2004).  More and co-workers studied the effects of ethanol extracts from eight 
South African medicinal plants used for traditional oral care and the majority of the plants 
showed inhibitory effects on  A. naeslundi, Actinomyces israelii, P. gingivalis, P. ntermmedia 
and S. mutans (More et al., 2008). Based on the accumulating evidences from different regions 
of the world, WHO is encouraging the use of plants as a tool for oral healthcare in areas where 
this is customary (WHO, 1987). Additionally, the Consensus Statement on Oral Hygiene 
(2000) stated that medicinal plants may have a role to play in the promotion of oral hygiene, 
and that evaluation of their effectiveness warrants further research to clearly define their anti-
microbial effects (Anonymous, 2000). 
 
Most studies investigating anti-microbial effects of medicinal plants on oral pathogens have 
utilized crude plant extracts. The crude extracts are usually obtained by grinding dried plant 
materials, followed by macerating in suitable solvent, centrifuging and using the supernatant 
after filtration as the test material. We argued that this method of obtaining extracts for testing 
may not truly reflect the way most of these plants are used traditionally for dental or oral care, 
especially in situations where the plant materials are used in fresh form. For example,  in 
Uganda and East African region, for treatment of teething syndrome, fresh leaves of 
Momordica foetida, Carissa edulis.Vahl (Mubiru et al., 1994) and Solanum nigrum (Kokwaro, 
1993) are pounded and the resultant paste applied or squeezed onto the gum. For treatment of 
toothache, fresh leaves of Ocimum gratissimum, Bidens pilosa,  (Mubiru et al., 1994) and the 
fresh stem bark of Zanthoxylum chalybeum  (Kokwaro, 1993) are chewed. To treat mouth 
wounds, fresh leaves from Hoslundia opposita are chewed (Hamill et al., 2003; Kokwaro, 
1993). Chewing sticks prepared from fresh stems or roots of Vernonia amygdalina, Euclea 
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latidens. Stapf, Cymbopogon nardus (Mubiru et al., 1994), Zanthoxylum chalybeum (Kokwaro, 
1993) Lantana trifolia and Teclea nobilis. Delile (Hamill et al., 2003) are also used to prevent 
or treat dental caries. The widespread use of fresh plant parts for traditional oral care prompted 
part of this thesis to assess the possibility of release of anti-bacterial substances from the fresh 
extracts/pulp juices produced during use, and to consider whether such a release could be of 
significance in the prevention of dental caries or periodontal diseases (Study I). 
 
1.3 Essential oils and oral pathogens  
Among the several classes of plant chemicals that have been used for medicinal purposes are 
the alkaloids, glycosides, flavonoids, phenolic compounds, quinones, tannins, and terpenoids 
(essential oils) (Allaker and Douglas, 2009; Janardhanan and Thoppil, 2004). Of particular 
interest are the essential oils because they have been used for hundreds of years and are still 
being used as components of herbal treatment for a variety of ailments (Janardhanan and 
Thoppil, 2004). Essential oils are aromatic, volatile products of secondary metabolism of 
many plants species, and are known to play varied roles in the plants, some of which include 
attraction of insects and protection of the plants against harmful microbial/viral attack. They 
can be found in almost every plant parts including roots, stems, leaves, flowers, fruits, seeds 
(Janardhanan and Thoppil, 2004; Raut and Karuppayil, 2014). Essential oils are not only 
complex, but also chemically heterogeneous. They are derived from Isoprene (2-methyl-1,3-
butadiene), a common organic compound that is widely distributed throughout the plant 
kingdom (Cowan, 1999). Plants producing essential oils belong to around 60 families, but 
only selected families like Alliaceae, Lamiaceae, Rutaceae, Myrtaceae, Apiaceae, 
Asteraceae, Lauraceae, Poaceae, Verbenaceae are known to produce essential oils of 
medicinal and industrial values (Raut and Karuppayil, 2014).  
 
Essential oils exhibit a variety of pharmacological effects including anti-oxidant (Bhalla et 
al., 2013) and anti-microbial (Hammer et al., 1999; Kalemba and Kunicka, 2003) properties 
and have thus found considerable range of pharmaceutical applications. A number of recent 
studies add to the evidences that essential oils are suitable additives in products used for the 
maintenance of oral hygiene or prevention of dental diseases. Perhaps, the most extensively 
studied essential oil is that from the Australian medicinal plants Melaleuca alternifolia 
(Family: Myrtaceae). The essential oil from this plant has been used medicinally for many 
years. Hammer and co-workers investigated the anti-bacterial effects of Melaleuca 
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alternifolia essential oil on a collection of  bacteria isolated from oral cavity and reported 
MIC and MBC values in the range 0.003–2.0% (v/v) (Hammer et al., 2003). Further, time-
kill assays showed that exposure of S. mutans and Lactobacillus rhamnosus to 0.5% (v/v) 
Melaleuca alternifolia essential oil resulted in >3 log reduction of viable cells within 30 
seconds (Hammer et al., 2003). Another study compared the anti-bacterial efficacies of 
Melaleuca alternifolia essential oil and other essential oils including manuka oil, eucalyptus 
oil, lavandula oil and rosmarinus oil against oral pathogens and found that, in addition to their 
inhibitory and bactericidal effects, most of the oils were able to inhibit the adhesion of S. 
mutans and P. gingivalis (Takarada et al., 2004). Another important medicinal plants in Asia 
is Cryptomeria japonica (Family: Taxodiaceae) (Cha et al., 2007). Essential oil from C. 
japonica was shown to exhibit strong anti-bacterial effects on several oral bacteria including 
Streptococcus spp., A. actinomycetemcomitans and P. gingivalis with MIC of 0.025–
0.5mg/ml (Cha et al., 2007). Essential oils have also been demonstrated to enhance the effect 
of chlorhexidine. When used in combination with chlorhexidine, essential oils of cinnamon 
and manuka were able to significantly reduce the amount of chlorhexidine required to inhibit 
the growth of oral pathogens (Filoche et al., 2005). These studies and others indicate that 
essential oil from medicinal plants can be used in oral health care products and in the 
maintenance of oral hygiene. And for many years now, ListerineTM (Essential Oil Rinse) has 
been in widespread use (Allaker and Douglas, 2009; Fine, 2010). The ListerineTM product 
contains four plant essential oils, namely, eucalyptol, menthol, thymol and methyl salicylate 
(Fine, 2010). 
 
A number of medicinal plants used for traditional treatment of oral diseases in Uganda belong 
to the aromatic plant families and are thus essential oils producing (Table 1). Given the 
potential of the essential oils in the promotion of oral health, a section of this thesis was 
focused on studying the inhibitory effects of essential oil from these aromatic plants on the 
growth of oral pathogens (Study II). 
 
1.4 Inflammation and anti-inflammatory effects of compounds of plant origin  
Inflammatory process may be defined as a sequence of events that occur in response to 
infection, trauma or toxic stimuli. The process of inflammation is essential for defense against 
pathogens and wound healing, and thus occurs throughout the human body. Acute 
inflammation is a type of inflammation that is of short duration, and usually occurs 
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immediately in response to trauma or infection. However, when the inflammation remains 
unresolved, it develops into chronic inflammation. This happens when the host immune and 
inflammatory responses are insufficient to remove or clear the microbial challenge which 
initiates and spreads the disease process. In chronic inflammation, tissue destruction and 
healing occur concurrently, but the balance is delicate and can easily shift towards destruction 
if environmental and certain host factors like genetic and systematic conditions favour it 
(Yucel-Lindberg and Bage, 2013). In the oral cavity, hundreds of species of aerobic and 
anaerobic bacteria are constantly present. Some of these species grow on tooth surfaces as 
complex, mixed colonies in biofilms (Socransky and Haffajee, 2005).  Certain Gram-
negative bacterial species such Porphyromonas gingivalis, Tannerella forsythia and 
Aggregatibacter actinomycetemcomitans that are present in the biofilms are known to initiate 
an inflammatory response that result to gingivitis. In diseases-susceptible individuals, 
gingivitis may progress to periodontitis (Bartold and van Dyke, 2013) 
 
The term “periodontal disease” is a collective term for the inflammatory disorders of 
gingivitis and periodontitis instigated by bacteria in the biofilms (Pihlstrom et al., 2005)   
Gingivitis is a mild, but common form of inflammation of the gingiva. Gingivitis is easily 
reversible by improvement in oral hygiene in healthy individuals. Periodontitis occurs when 
the gingival inflammation persist, and extend deep into the tissues and thus become chronic. 
This leads to irreversible destruction of the supporting structures of the teeth. The typical 
characteristics of periodontitis are destruction of the periodontal ligaments, gingival tissues 
and alveolar bone loss (Pihlstrom et al., 2005). 
 
Inflammatory response in the periodontal tissues and other parts of the body are orchestrated 
by a complicated interaction between mediators of inflammation and inflammatory cells 
(Kinane et al., 2011). Cytokines are the soluble proteins that serves as mediators of cellular 
communication and are involved in many steps of the inflammatory response.  More than 
100 members of the cytokine family and their specific receptors have been identified 
(Haddad, 2002). Cytokines has been classified as pro-inflammatory and anti-inflammatory, 
depending on the way they influence inflammatory process. Pro-inflammatory cytokines (e.g 
IL-1β, TNf-α, IL-6 and IL-8) are known to promote the inflammatory process, whereas the 
anti-inflammatory cytokines (e.g IL-4, IL-10) suppress the activity of pro inflammatory 
cytokines (Dinarello, 2000; Opal and DePalo, 2000). 
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Cytokines are synthesized by nearly every cell including migrating cells (e.g masts cells, 
macrophages and neutrophils) as well as resident cells such as gingival fibroblasts and 
epithelial cells.  After release; cytokines can act either locally or systemically. Due to their 
redundant and pleiotropic actions, cytokines function in a network in which one cytokine can 
induce its own production or even the secondary generation of other cytokines. Furthermore, 
most cytokines are known to be involve in the activation of transcription factors and protein 
kinases that in turn regulate the expression of many target genes that are vital for the 
maintenance of the inflammatory process (Kracht and Saklatvala, 2002) For instance, 
cytokine may be responsible for induction of several enzymes (COX-2, NO synthase, 
adhesion molecules for leukocyte) that augment blood flow and recruit leukocytes to the site 
of infection (Kracht and Saklatvala, 2002). A different group of cytokines, known as 
chemokine (including IL-8, MCP-3) have the ability to chemo attract and activate leukocytes 
at the site of inflammation (Luster, 1998; Wong and Fish, 2003). Binding of chemokine to 
their specific receptors allows rolling leukocytes to become firmly adherent and to 
transmigrate to the target tissues, a process which depends on the activation of adhesion 
molecules, mainly integrins (Luster, 1998). 
Cytokines (and chemokines) are now known to be involved in the pathophysiology of many 
inflammatory diseases including periodontitis (Hopkins, 2003; Yucel-Lindberg and Bage, 
2013). The pathological states in periodontitis have been linked to an imbalance of the 
cytokines network in the periodontal tissues following stimulation by periodontopathic 
bacteria in the dental biofilm and /or their products. The continuous production of the various 
pro-inflammatory cytokines, including interleukin (IL) 1β, IL-6, IL-8, TNF-α), as well as of 
prostaglandin E2 (PGE2) following this stimulation had been associated with periodontal tissue 
destruction (Okada and Murakami, 1998). 
 
The Consensus of the Seventh European Conference on Periodontology underscored the need 
to develop new and more effective preventive and treatment approaches for periodontal 
diseases which embraces inflammation resolution as well as direct management of micro biota. 
(Tonetti and Chapple, 2011). Compounds that are able to selectively interfere with production 
and/or functions of cytokines, thus bringing about resolution of inflammation in the 
periodontal tissues would constitute an important alternative for treatment of periodontal 
diseases (Tonetti and Chapple, 2011). In an effort to identity such compounds, part of this 
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thesis was devoted to investigation of the effects of essential oils from the Uganda medicinal 
plants on the production of pro-inflammatory cytokine (IL-6, IL-8 and prostaglandin E2) by 
human gingival fibroblasts. The essential oils that were investigated were those with 
promising anti-bacterial effects on periodontopathic bacteria (Study III). 
 
The potential effects of essential oils from medicinal plants on production of inflammatory 
cytokines/mediators have previously been reported by other authors. Tipton and co-workers 
found essential oil from Commiphora molmol (myrrh oil) to significantly reduced IL-β 
stimulated production of IL-6 and IL-8 by gingival fibroblasts cells (Tipton et al., 2003). The 
water soluble fraction of essential oil of Melaleuca alternifolia (tea tree oil) was found to 
inhibit lipopolysaccharide induced production of the inflammatory mediators TNF-α, IL-β 
and IL-10 by human peripheral blood monocytes approximately 50% and that PGE2 by about 
30% (Hart et al., 2000). 
 
1.5 Toxicity testing of medicinal plants 
Plants used in traditional medicine are assumed to be safe. This safety is based on their long 
usage in the treatment of diseases according to knowledge accumulated over centuries 
(Fennell et al., 2004). However, a study carried out to investigate potential hazards associated 
with long –term effect of 51 plants commonly used in South African traditional medicine 
found that most of these plants either caused DNA damage, chromosomal aberration or 
chromosomal lagging in human white blood cells (Taylor et al., 2003). It cannot therefore be 
taken for granted that medicinal plants are void of toxic effects. Some authors have thus 
recommended that pharmacological studies on medicinal plants should always be followed 
by toxicological screening (Cos et al., 2006).   
 
Toxicity may be tested in-vivo using animals such as rats, guinea pigs, monkeys, or in-vitro 
using cell lines. In-vivo animal models are usually used to provide evidence of systemic or 
organ toxicity. In vitro cytotoxicity testing of medical/dental materials on host cells is usually 
recommended before commencement of other advanced systemic or organ toxicity tests 
(ISO, 2009). As a first step towards other advanced tests, we tested the cytotoxicity of 
selected plant extracts using human gingival fibroblasts model (Study III). The human 
gingival fibroblasts are suitable model because they are the predominant connective tissue 
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cells (65 % of the total cell population) of the periodontal tissue and are exposed to the plant 
extracts during use.  
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2 AIMS OF THE THESIS  
2.1 Overall aim  
The overall aim of this thesis was to investigate the Ugandan medicinal plants that are used 
traditionally for oral care for anti-bacterial, cytotoxic and anti-inflammatory effects.  
 
2.2 SPECIFIC AIMS  
i. To test the anti-bacterial effects of fresh pulp juice obtained from 16 commonly used  plant 
species on cariogenic and periodontopathic bacteteria.. 
ii. To test the anti-bacterial  effects of solvent extracts (water, hexane, methanol) obtained 
from the 16 commonly used  plant species on cariogenic and periodontopathic bacteteria. 
iii. To test anti-bacterial effects of essential oils  from selected  aromatic medicnal plants on 
cariogenic and periodontopathic bacteteria. 
iv. To test the cytotoxic effects of the promising plant extracts on the human gingival  
fibroblasts. 
v. To test the effects of the promising extracts on the  production of pro-inflamatory cyotkines. 
vi. To identify the bioactive molecules in the most active extracts. 
 
 
 
 
 
 13 
 
3 MATERIALS AND METHODS  
3.1 Plant materials used in the study and their collection  
The plant materials used in this study were collected from the regions of Uganda where they 
are used traditionally for treatment of various form of dental and oral diseases. The plants were 
collected following information obtained from literature. Collection was carried out in 
consultation with the local people or traditional healers in the areas, and local names of the 
plants got from literature were used to aid identification. The plants were collected in 2 parts: 
the first part was used for scientific authentication; the second part was for experimental use. 
The first part, which consisted of a representative sample (i.e. stem, leaves, flowers and fruit, 
if any) was pressed between two boards and taken to the botanist at the Herbarium, Department 
of Botany, Makerere University for scientific authentication. The specimens were archived at 
the Herbarium at the Department of Botany, Makerere University after voucher specimen 
numbering. The following information were included in the voucher of each specimen: 
Voucher number, confirmed scientific name, local plant name, dental/oral diseases treated, 
district of collection, county, sub-county, parish, village, habitat and date of collection. The 16 
medicinal plants collected are shown in Table1. The second part of plants collection included 
parts of the plant that are used traditionally and the collection was handled depending on the 
experiment that was to be carried out. Plants destined for extraction of fresh pulp juice or 
essential oils were transported in ice-cooled boxes and stored at -80 ᴼC at the Department of 
Medical Microbiology, Makerere University, until use or transportation to Karolinska 
Institutet, Sweden. Schematic describing the studies done on the medicinal plants is shown in 
Figure 1.  
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Table 1. Uganda medicinal plants used for traditional treatment of dental/oral diseases 
 
Scientific name/plant 
family/voucher numbera 
 
Local name/tribe District 
of collection 
Plant part: Ethno-medical 
use(s) (references) 
Dental/oral 
disease(s) 
treated 
Carissa edulis.Vahl 
(APOCYNACEAE) 
[FO-001] 
Achuga/Langi                            Apach LT: pound, add cold water 
and squeeze few drops on 
gum 
(Mubiru et al., 1994) 
Teething 
syndrome 
Bidens pilosa 
(ASTERACEAE) 
[FO-002] 
Enyabarashana/Rukiga Kabale LT: chew 
(Mubiru et al., 1994) 
Toothache 
Crassocephalum vitellinum   
(ASTERACEAE) 
[FO-003] 
Paroti / Kupsabiny Kapchorwa LT: Dry, burn and  rub ash 
on false teeth 
(Mubiru et al., 1994) 
Teething 
syndrome 
Helichrysum odoratissimum   
(ASTERACEAE) 
[FO-004] 
Chebushe / Kupsabiny Kapchorwa LT: Dry, burn and  rub ash 
on false teeth 
(Mubiru et al., 1994) 
Teething 
syndrome 
Vernonia amygdalina 
(ASTERACEAE)        
[FO-005] 
Okello-okello/Langi Apach ST: use to brush teeth 
(Mubiru et al., 1994) 
Dental caries 
Euclea latidens. Stapf 
(EBENACEAE)               
[FO-006] 
Amuru-dyek/Langi Apach RT: Use to brush teeth 
(Mubiru et al., 1994) 
Dental caries 
Momordica foetida                     
K.Schumach 
(CUCURBITACEAE) 
[FO-007] 
Bomo/Langi Apach LT: Pound, squeeze juice 
onto the wound 
(Mubiru et al., 1994) 
Teething 
syndrome 
 
Hoslundia opposita   
(LAMIACEACE)       
[FO-008] 
Kamunye/Baganda Masaka LT: Chew  
(Hamill et al., 2003; 
Kokwaro, 1993) 
Mouth 
wounds 
Ocimum gratissimum              
(LAMIACEACE)            
[FO-009] 
Omujaja/Rukiga Kabale LT: Chew 
(Mubiru et al., 1994) 
Toothache 
Cymbopogon citratus 
(POACEAE)          
[FO-010] 
Kasubi/Baganda Kampala  LT: taken as tea 
(Mubiru et al., 1994) 
Bad breath 
Cymbopogon nardus    
(POACEAE)                     
[FO-011] 
Omute/Rukiga Kabale Root: to brush teeth 
(Mubiru et al., 1994) 
Bad breath, 
dental caries. 
Clematis hirsuta. Guill. & 
Perr.    
(RANUNCULACEAE) 
[FO-012] 
Adwe/Langi Apach LT: pound and apply paste 
on painful tooth, 
Infusion drunk 
(Kokwaro, 1993) 
Toothache  
Sore throat 
Teclea nobilis. Delile  
(RUTACEAE)          
[FO-013] 
Nzo/Baganda Rakai ST: Use to brush teeth 
(Hamill et al., 2003) 
Dental caries 
Zanthoxylum chalybeum    
(RUTACEAE)    
[FO-014] 
Owucu/Langi 
Songowowo/Pokot 
Apach RT: Use to brush 
ST: Bark chewed  
(Kokwaro, 1993) 
Dental caries 
Toothache 
Solanum nigrum   
(SOLANACEAE) 
[FO-015]                                       
Osuga/Langi Apach LT, FT:  crush into paste 
and rub on the gum 
(Kokwaro, 1993) 
Teething 
syndrome 
Lantana trifolia                 
(VERBENCAEACE)               
[FO-016] 
Kayuki-yuki/Baganda Masaka ST: Use as toothbrush to 
clean and freshen 
LT: infusion swallowed 
(Hamill et al., 2003; 
Odongo et al., 2011) 
Oral 
Hygiene 
Tonsillitis 
a 
Voucher specimen number at the Herbarium, Makerere University; FT=Fruit; LT=Leave; RT=Root; ST=Stem. 
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Figure 1. Schematic describing the studies done on the medicinal plants 
 
3.2 Study I 
3.2.1 Preparation of fresh pulp juice 
To obtain fresh pulp juice for testing, fresh plant materials (stored at -80 ᴼC) were thawed, 
rinsed with distilled water, and routinely 50 g cut into small pieces and a manual fruit juicer 
(Anjali fruit juicer, JL01,  Mumbai, India) (Figure 2) used to crush and express the juice from 
the fresh plant pieces. The expressed juice was prepared for testing immediately after 
preparation at full strength (100%), 50% and 25% dilutions. The dilutions were made using 
brain heart infusion (BHI) broth.  
16 
commonly 
used plant 
species were 
identified 
from 
literature and 
collected for 
the study 
Fresh pulp juice 
and solvent 
extracts 
(Hexane, 
methanol, water) 
from the 16  
plants were 
tested for anti-
bacterial effects 
on cariogenic & 
periodontopathic 
bacteria 
 
Essential oil 
extracts from 10 
aromatic plants 
were tested for 
anti- bacterial 
effects on 
cariogenic & 
periodontopathic 
bacteria. 
Chemical 
composition of 
the oils were 
analyzed using 
GC-MS 
Study I 
(Anti-bacterial 
effects) 
Study II 
(Anti-bacterial 
effects) 
 
Essential oils from 4 
promising plants 
were tested for 
cytotoxicity and 
anti-inflammatory 
effects using human 
gingival fibroblasts 
model 
Study III 
Cytotoxicity & anti-
inflammatory effects)  
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Figure 2. Anjali fruit juicer 
3.2.2 Preparation of solvent extracts      
Solvent extracts for the study were obtained from dry plant materials. For woody plant species 
(trees and shrubs), the stem/stem bark, leaves, and roots were collected, processed and later 
tested separately, while for herbaceous plant species, the aerial parts consisting of leaves and 
stems were processed together. The preparation method of plant materials for solvent extract 
was adapted from Matu and van Staden (2003) with modifications. The plants were first dried 
at room temperature for a period of 2-3 weeks, and then milled into powder with a Brook 
Crompton Series 2000 mill (Huddersfield, UK) at the Natural Chemotherapeutics Research 
Laboratories (NCRL), Kampala, Uganda. The powders were packed in re-sealable plastics bags 
and stored in the dark at room temperature until solvent extraction. 
 
In order to extract all possible active compounds present in the plant, three solvents of 
increasing polarity were used. The solvents used were: n-hexane (non-polar), methanol (polar) 
and water (very polar). Hexane and methanol extracts were obtained by routinely macerating 
300-500 g of the powdered materials in approximately 600-2000 mls of hexane or methanol, 
with occasional shaking for 72 hours, and filtered using Whatman grade 1 filter paper. The 
filtrate was concentrated using a rotary vacuum evaporator (Heidolph, Germany) to 
approximately 50 mls and the resultant concentrate dried in the oven at 40-50 ᴼC until weight 
remain constant. The extract was stored at 4 ᴼC until use. For the water extract, 10-35 g of the 
powdered plant material was heated in 200-500 mls of distilled water to boiling point for about 
20 minutes and the extract filtered using Whatman grade 1 filter paper. The filtrate was 
concentrated using a freeze dryer and the residue stored in re-sealed plastic bags at 4 ᴼC until 
use.  
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3.2.3 Bacterial strains and cultivation 
3.2.3.1 Bacteria strains 
The bacterial strains that were used in study I were obtained from the culture collection of the 
University of Goteborg (CCUG). The strains used include the dental caries associated 
Streptococcus mutans (CCUG 6519 T), Streptococcus sobrinus (CCUG 25735 T), 
Lactobacillus acidophilus (CCUG 5917 T), and the periodontal diseases associated 
Porphyromonas gingivalis (CCUG 25226), Aggregatibacter actinomycetemcomitans (CCUG 
56173) and Tannerella forsythia (CCUG 21028 AT).  
 
3.2.3.2  Bacterial cultivation 
Growth conditions: The bacteria were cultivated as previously described (Sofrata et al., 2008) 
but with modifications. S. mutans was grown for 2 days under anaerobic conditions on 
Colombia base agar supplemented with 5% sheep blood. L. acidophilus was grown for 2 days 
under anaerobic conditions on Colombia base agar supplemented with 5% sheep blood. A. 
actinomycetemcomitans was grown for 2 days under anaerobic conditions on Colombia base 
agar supplemented with 5% sheep blood and incubated in 95% air and 5% carbon dioxide. P. 
gingivalis was grown anaerobically for 4 days on Colombia base agar supplemented with 
hemin (0.05mg/ml), vitamin K (0.01mg/ml) and 5% sheep blood. T. forsythia was grown 
anaerobically in chocolate agar supplemented with hemin (0.05mg/ml) and vitamin K 
(0.01mg/ml). 
 
3.2.4 Anti-bacterial activity testing 
3.2.4.1 Fresh pulp juice 
A simple agar well-diffusion assay was used to test for anti-bacterial activities in the fresh pulp 
juice. For testing, S. mutans, S. sobrinus, L. acidophilus and A. actinomycetemcomitans were 
suspended in phosphate buffered saline (PBS) and P. gingivalis and T. forsythia were 
suspended in peptone yeast glucose. The density of each bacterial suspension was adjusted 
using a spectrophotometer to equal that of 0.5 McFarland standards (108 colony forming 
units/ml). Each bacterial suspension was swabbed over the surface of their respective special 
agar plate prepared as described in section 3.2.3.2 above and thereafter a 7 mm core of agar 
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was removed from three positions on each plate (Figure 3). The wells were aseptically filled as 
follows: first well was filled with 0.1mls of fresh pulp juice or dilutions; the second with 0.1mls 
of doxycycline (30µg) solution in normal saline to act as positive control; the third with 0.1 
mls of BHI broth to act as negative control. After holding the plate for 1 hour, the plates were 
incubated under the conditions described in section 3.2.3.2 above followed by the measurement 
of inhibition zones in millimeters. The experiments were repeated three times and the anti-
bacterial activity was expressed as the ratio of the inhibition zone produced by plant extract 
and the inhibition caused by the doxycycline control in the plate (Vlietinck et al., 1995). 
 
Figure 3. Positions of well in the agar plate and inhibition zones 
 
3.2.4.2 Solvent extracts 
A total of 66 solvent extracts from 15 plant species were prepared for testing.  One plant species 
(Carissa edulis) could not be obtained for solvent extraction. Screening of the extracts for anti-
bacterial activity was done using agar-dilution assay (Rios et al., 1988) and the special media 
prepared for the bacteria in section 3.2.3.2 above were used. The extracts were first screened 
for activity at a maximum concentration of 1mg/ml as recommended for crude plant extracts 
(Cos et al., 2006) and if active, the minimum inhibitory concentrations (MIC) then determined 
following the European Committee for Antimicrobial Susceptibility Testing (EUCAST) 
protocol for determination of MIC of anti-bacterial agents by agar dilution (EUCAST, 2000) 
with modifications. For testing at a maximum concentration of 1mg/ml, 0.5mls of the extract 
at a concentration of 20mg/ml in 10% dimethyl sulfoxide (DMSO) or PBS (for water extract) 
was added to 9.5mls of melted agar held at 45-50 ᴼC in a falcon tube, shaken and poured in 
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petri-dish to harden. The final in-test concentration of DMSO in the agar was 1% (v/v). 
Preliminary tests had shown this final DMSO concentration not inhibitory to bacterial growth. 
The bacteria were suspended as described in section 3.2.4.1 above and each suspension 
adjusted to give 107 CFU/ml. Using a micropipette, 1µl of the suspension (104 live bacterial 
cells) was spotted onto the surface of agar plates and the plate allowed to stand until the 
inoculum was completely absorbed (EUCAST, 2000). A plate with 1% DMSO (solvent 
control) and another incorporated with 10µg doxycycline were also inoculated to serve as 
positive and negative controls respectively. The plates were incubated anaerobically at 37 ᴼC 
for 24 to 48 hours. The extract was declared active if it completely inhibited visible growth of 
bacteria as judged by the naked eye, disregarding a single colony or a thin haze within the area 
of the inoculated spot (EUCAST, 2000) 
 
For MIC determination, two fold dilutions of the extracts in DMSO or PBS (for water extract) 
were prepared at final in-test concentrations ranging from 0.0313 to 1 mg/ml, and the bacteria 
prepared and spotted as above. The MIC of doxycycline for each bacterium was also run to 
validate the procedures. The final in-test concentrations of doxycycline ranged from 7.8×10-5 
to 2.5×10-3 mg/ml. MIC was the lowest concentration of the extract that completely inhibited 
visible growth of bacteria as judged by the naked eye, again disregarding a single colony or a 
thin haze within the area of the inoculated spot (EUCAST, 2000). All tests were performed in 
duplicates   
 
3.2.5 Graphical summary of study I 
Graphical summary of study I is shown in Figure 4 
Figure 4. Graphical summary of study I 
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3.3 Study II 
3.3.1 Plant materials for extraction of essential oils 
In study II, ten aromatic plants were selected for extraction of essential oils. The ten plants 
selected were B. pilosa, H. odoratissimum, V. amygdalina, H. opposita, O. gratissimum, C. 
citratus, C. nardus, T. nobilis, Z. chalybeum and L. trifolia. These plants were selected from 
the original 16 plants cited in Table 1 on the basis of their grouping in the aromatic plant  
families (Raut and Karuppayil, 2014; Skaria et al., 2007). The aromatic plants families from 
where the species were picked include Asteraceae, Lamiaceae, Poaceae, Rutaceae, and 
Verbenaceae. 
 
3.3.2 Extraction of essential oil 
To extract essential oil, 300g of cut pieces of fresh plant material was mixed with 600 ml of 
distilled water and the mixture subjected to hydro-distillation for 4-5 hours using glass 
distillation apparatus as shown in Figure 5. The distillate (oil/water mixture) was collected, and 
the essential oil extracted from the distillate with HPLC grade hexane using a separating funnel. 
Anhydrous magnesium sulphate was added to the hexane extract to remove any trace of water. 
After filtration, hexane was evaporated with a rotary evaporator (Rotavapor-R210, Buchi, 
Switzerland). The essential oil obtained from each plant was weighed and the yield calculated 
as percentage of fresh starting plant material. 
 
 
 
 
 
 
 
 
Figure 5. Steam distillation set-up. 
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3.3.3 Bacterial strains and cultivation 
3.3.3.1 Bacterial strains 
Gram-negative bacterial strains: Periodontopathic bacteria A. actinomycetemcomitans 
(HK 1519) and P. gingivalis (ATCC 33277). 
Gram-positive bacterial strains: Cariogenic bacteria S. mutans (CCUG 27624) and L. 
acidophilus (NCTC 1723) and the non-oral pathogenic bacterium Bacillus megaterium 
(BM11). 
 
3.3.3.2 Bacterial cultivation  
Growth conditions: All the bacteria were propagated as previously described (Sofrata et al., 
2011). A. actinomycetemcomitans was propagated on Columbia base agar supplemented with 
0.1% tryptophan and 5% citrated horse blood in 5% CO2 atmosphere. P. gingivalis was 
propagated for 6 days on Colombia base agar supplemented with hemin (0.05mg/ml), vitamin 
K (0.01mg/ml) and 5% citrated horse blood in an anaerobic atmosphere. S. mutans was grown 
in Brain Heart Infusion (BHI) agar plates for 2 days in 5% CO2 atmosphere. L. acidophilus 
was propagated for two days on Lactobacilli MRS agar plates in 5% CO2. B. megaterium was 
propagated overnight in air on Luria agar plates. All bacterial were incubated at 37 ᴼC. 
 
3.3.4 Analysis of chemical composition of essential oils 
The chemical composition of the essential oils were analyzed using a Varian 3400 Gas-
Chromatography (GC) connected to a Finnigan  SSQ 7000 Quadropole Mass Spectrometer 
(MS). The GC was equipped with a split/splitless injector (splitless mode 30 seconds), a DB-
wax capillary column (J & W Scientific, Folsom, CA, and USA, 30m long, 0.25mm inner 
diameter and 0. 25µm film thickness).  The injection temperature was isothermally set at 230 
ᴼC. The carrier gas (Helium, 99.99%, Stransmollen AB, Ljungby, Sweden) was delivered at 
a constant pressure of 10 psi. A representative temperature program was 40 ᴼC for 1 minute, 
followed by an increase in temperature at a rate of 3 ᴼC /minute up to 235 ᴼC, and thereafter 
the temperature was maintained at 235 ᴼC for 14 minutes, making a total analysis time of 80 
minutes. Transfer line temperature was kept at 235 ᴼC and the MS ion source temperature 
was 150 ᴼC. Mass spectra were obtained for 70 eV with a mass range of 30 to 600m/z in 
positive mode. The software program, X-calibur 2.0 was used for acquiring and analysis of 
the GC-MS data. For analysis, dried samples of essential oils were redissolved in hexane to 
a concentration of 5 µg/µl and 1µl injected into the GC. Identification of compounds in the 
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oils were made by comparison of their MS with compounds in the Finnigan NIST library-
2008 and final authentication of selected compounds made by analyzing available 
compounds at the same parameters as those used for the essential oils. 
 
3.3.5  Assessment of growth inhibitory effects of the essential oils 
Assessment of growth inhibitory effects was done using broth dilution assay as previously 
described (Sofrata et al., 2011), with modifications. Colonies of A. actinomycetemcomitans and 
P. gingivalis were re-suspended in Peptone Yeast Glucose medium. S. mutans colonies were 
re-suspended in BHI broth. Colonies of L. acidophilus were re-suspended in Lactobacilli MRS 
broth. Colonies of B. megaterium were re-suspended in Luria broth. The optical densities of all 
bacterial suspensions were adjusted to 0.5 at λ590nm wavelength. All bacteria were further 
diluted in fresh growth medium 104 fold prior to the test. The bacterial suspensions were 
incubated for 90 minutes in their respective growth medium at 37 ºC in the presence of different 
concentrations of essentials oils. Dilutions of essential oils were prepared in dimethyl sulfoxide 
(DMSO) and 5µl of each dilution or undiluted oil was added to 495µl of respective growth 
medium to obtain final concentrations of 1%, 0.1% and 0.01%. To the solvent control, 5µl of 
DMSO was added. Chlorhexidine was used a positive control, diluted to final concentrations 
of 1%, 0.02% and 0.05% and tested against clinically relevant bacteria A. 
actinomycetemcomitans, P. gingivalis, S. mutans, L. acidophilus). After 90 minutes, the 
bacterial suspensions were spread on agar plates with respective growth medium and grown as 
in section 3.3.3.2 above. The number of live bacteria was determined by counting the colonies 
on each plate, which equals colony forming units (CFU). Growth inhibitory effects was 
expressed as the percentage of the colony forming units (CFU) in the presence of plant essential 
oils or chlorhexidine to the CFU in the control plate ((CFU in test / CFU in control) × 100).  
All tests were done in duplicates and repeated twice. 
 
3.3.6 Data analysis  
Data anaylsis was performed using Prism 6 (GraphPad Software, San Diego, CA, USA). 
Independent Student’s t-test was used to analyze for statistical differences in CFU in the control 
plate and CFU in each tested concentration of the oil or chlorhexidine.  Values of p < 0.05 were 
regarded as significant (n=4). 
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3.4 Study III    
3.4.1 Plant essential oil 
The essential oils used in study III were selected from the oils which were investigated in study 
II. Essential oils from the following plants were selected:  B. pilosa, C. nardus, Z. chalybeum 
and O. gratissimum. The oils were selected because they had shown good anti-bacterial effects 
on the Gram-negative periodontopathic bacteria A. actinomycetemcomitans and P. gingivalis. 
 
3.4.2 Chemicals 
The following chemicals were used in study III: Dulbecco’s Modified Eagle's Medium 
(DMEM), Phosphate Buffer Saline (PBS) (without calcium and magnesium), Fetal Bovine 
serum (FBS), trypsin (0.25%), Penicillin-Streptomycin-Glutamine (50 mg⁄mL) were purchased 
from Invitrogen Life Technologies (Paisley, UK). 3-(4, 5-dimethylthiazolyl-2)-2, 5-
diphenyltetrazolium bromide (MTT) Cell Viability Assay Kit was purchased from Abnova 
Corporation (Taipei, Taiwan). Human IL-6 and IL-8 Douset enzyme-linked immunosorbent 
assay (ELISA) kit was purchased from R&D systems (Minneapolis, MN, USA). Prostaglandin 
E2 monoclonal enzyme immunoassay (EIA) kit was obtained from Cayman Chemicals (Ann 
Arbor, MI, USA). 
 
3.4.3 Gingival biopsies  
In this thesis, human gingival fibroblast cells were used to test for cytotoxicity of the essential 
oils and the effects of the oils on production of pro-inflammatory mediators. The human 
gingival fibroblast cells used were originally established from gingival biopsies obtained from 
7 systemically and periodontal healthy donors (aged 7–12) with approval of the Ethical 
Committee at the Huddinge University Hospital, Stockholm. The biopsies from the gingival 
tissues were taken during dental surgical procedures that was part of a planned patient care 
treatment and patients were therefore not exposed to any other additional discomfort. The 
patients gave their informed consent for their gingival biopsies to be used for establishment of 
primary gingival fibroblasts cells that were used in this research 
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3.4.4 Gingival fibroblast cell culture 
 For the experiments, the gingival fibroblast cells were cultured in DMEM supplemented with 
5% FBS and 1% Penicillin-Streptomycin-Glutamine (50 mg⁄mL), grown as monolayer cultures 
in corning cell culture flask, 75 cm2, (NuncTM, Roskilde, Denmark) and incubated at 37 ᴼC and 
5% CO2. The media was replaced every 3 to 4 days until about 80% confluence was reached 
followed by detachment with 0.025% trypsin for experimental use. Cells at passages 10-15 
were used in all experiments to ensure stability. 
 
3.4.5 Cytotoxicity assay 
The cytotoxic effects of the essential oils on the human gingival fibroblast cells was assessed 
by estimating the viability of the cells after exposing the cells to essential oils dissolved in 
ethanol. Cell viability was determined by MTT assay. The assay is based on the reduction of 
yellow tetrazolium MTT by the mitochondrial succinate dehydrogenase enzymes to insoluble 
formazan-blue crystals. Only viable cells with active mitochondria reduce significant amounts 
of MTT and the value of absorbance obtained by the plate reader is directly proportional to 
viability of the cells (Mosmann, 1983). The MTT Cell Viability Kit purchased from Abnova 
(Taipei, Taiwan) was used according to the manufacturer’s instruction. 
 
For the experiment, the human gingival fibroblast cells were seeded at a density of 10,000 cells 
per well in in 96-well tissue culture plates (VWR International, Leuven, Belgium) and 
incubated for 48 hours to allow cell adherence and cells to grow to the exponential phase of 
growth. The medium was then removed and cells washed twice with serum-free medium and 
thereafter incubated in serum –free medium with increasing concentrations of the oils 
solubilized in ethanol. The final maximum concentration of ethanol in medium was 0.55% and 
this was not cytotoxic to cells. After 24 hours, 100µl of MTT solution was added and plates 
were incubated for 4 hours at 37°C. The formazan crystals formed were solubilized with 
solubilizing solution and the absorbance determined at 620nm by a microplate 
spectrophotometer (Labsystem Multiskan MS, Helsinki, Finland). The average of the blank 
control was determined and the amount subtracted from all absorbance values. The 
concentration at which 50% of the cell were killed (IC50) for each essential oil was determined 
as recommended in the MTT kit. For each essential oil, the experiment was run in triplicates 
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and repeated three times and the average IC50 calculated. The lower the IC50 value, the more 
toxic the oil, because less is required to achieve killing of the cells. 
 
3.4.6  Measurement of IL-6, IL-8 and PGE2 
For measurement of IL-6, IL-8 and PGE2, gingival fibroblasts cells were seeded in 24 –well 
plate at a density of 40,000 cells per well (in 300µl medium) and incubated for 24 hours. The 
medium was removed and cells rinsed twice with serum-free medium and thereafter stimulated 
with 300 pg/ml IL-β alone or 300pg/ml IL-β with increasing sub-cytotoxicity concentrations 
of oils and incubated for further 24 hours. The supernatants was collected and stored at -80ᴼC 
until measurement of IL-6, IL-8 or PGE2 levels. The amount of IL-6 and IL-8 in the 
supernatants was determined using the Douset ELISA kit (R&D systems, Minneapolis, MN, 
USA). The amount of PGE2 was determined using the PGE2 monoclonal EIA kit (Cayman 
Chemicals, Ann Arbor, MI, USA). The kits were used according to the manufacturers’ 
instructions. The experiment was performed in triplicates and repeated three times. 
 
3.4.7 Data Analysis 
The statistical analyses in study III were performed using Prism 6 (GraphPad Software, San 
Diego, CA, USA). Sigmoidal dose responses and non-linear regression analyses were 
undertaken to identify the IC50  (concentration that causes a reduction by half of the activity of 
mitochondria1 dehydrogenase) values of each essential oil. To evaluate differences in IC50
 of 
the essential oils and effects of essential oils on the IL-1β induced production of pro-
inflammatory cytokine (IL-6, IL-8 and prostaglandin E2), one-way ANOVA combined with 
Tukey’s post hoc test was used. Values of p < 0.05 were regarded as significant. 
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4 RESULTS  
4.1 STUDY 1 
4.1.1 Fresh pulp juice 
Fresh pulp juice prepared from 16 medicinal plants (10 families) used for traditional 
treatment of various forms of oral and dental diseases (Table 1) were screened for anti-
bacterial activities against six different dental bacteria, namely, S. mutans, S. sobrinus, L. 
acidophilus and A. actinomycetemcomitans, P. gingivalis and T. forsythia. The pulp juice 
were tested at full strength without dilutions (100%), and at 50 % and 25% strengths. Fresh 
pulp juice from three plant species, namely Z. chalybeum, E. latidens, and O. gratissimum 
exhibited anti-bacterial activity against one or more bacterial species. The results from the 
anti-bacterial activity studies from the fresh pulp juice showing positive results are presented 
in Table 2. Fresh pulp juice from Z. chalybeum and E. latidens showed activity against all 
the bacterial species tested and at all strengths. The most active fresh pulp juice was from Z. 
chalybeum. It exhibited the best activity against L. acidophilus with the undiluted fresh pulp 
juice and 25% strength producing 63% and 45% zones of inhibition respectively, compared 
to the doxycycline control. Fresh pulp juice from O. gratissimum exhibited mild anti-bacterial 
activities on two bacterial species, A. actinomycetemcomitans and T. forsythia, at 100% and 
50% strengths. 
Table 2. Anti-bacterial activity of fresh pulp juice from the Ugandan medicinal plantsa 
 
Botanical name Plant 
Part 
testedb 
Juice 
strenghtc 
Anti-bacterial activityd 
A.ae P.g T.f S.m S.s L.a 
Euclea latidens. Stapf                 
 
Root bark  100 35 34 35 35 34 56 
50 32 31 32 30 32 51 
25 26 26 29 27 24 42 
 Ocimum gratissimum                             
 
Leave 100 27 - 33 - - - 
50 21 - 26 - - - 
25 - - - - - - 
Zanthoxylum chalybeum              Root bark 100 52 42 38 48 37 63 
50 47 31 32 39 33 52 
25 41 23 26 32 27 45 
aThe results are the mean of three replicates and only active plants shown. 
bThe part traditionally used for treating dental disease was selected for testing 
c Fresh pulp juice tested at 100%, 50% and 25% strengths. 
dAnti-bacterial activity expressed as percentage of inhibition zone of fresh pulp juice to the inhibition zone of 
the doxycycline (30µg) control. 
e Microorganisms tested: A.a =Aggregatibacter actinomycetemcomitans; P.g = Porphyromonas gingivalis; 
T.f = Tannerella forsythia; S.m= Streptococcus mutans; S.s =Streptococcus sobrinus, L.a= Lactobacillus 
acidophilus 
_ No inhibition zones  
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4.1.2 Solvent extracts  
Extracts from 15 plants species were screened for anti-bacterial activities. Hexane, methanol, 
water extracts were prepared from leaves, stems, root bark or whole plant. Altogether, a total 
of 66 extracts were screened. The extracts were first screened at maximum concentration of 
1mg/ml, and if found active, the MIC was then determined. The MIC of active extracts are 
summarized in Table 3. Hexane extract from the aerial part of H. odoratissimum exhibited the 
best activity with MIC ranging from 0.0125 to 0.5mg/ml on all the bacteria tested except A. 
actinomycetemcomitans. Methanol extract from L. trifolia was active on all bacteria tested 
with MIC ranging 0.25 to 1mg.ml. L. acidophilus was sensitive to plant extracts with all three 
solvents. The MIC of doxycycline (run concurrently to validate the procedures) ranged from 
1.56×10-4 to 12.5×10-4 mg/ml. 
Table 3. Minimum inhibitory concentrations of solvent extracts with anti-bacterial activity   
Plant species Plant 
part/Ea 
MIC (mg/ml) 
A.ab P.g T.f S.m S.s L.a 
Crassocephalum vitellinum      AE/H  1     
Helichrysum odoratissimum      AE/H  0.125 0.5 0.25 0.125 0.125 
Helichrysum odoratissimum      AE/M  0.5  1 1 0.5 
Vernonia  amygdalina                 LF/M 1      
Euclea latidens SB/M      0.5 
Momordica foetida             RT/M      1 
Momordica foetida             RT/W      0.5 
Hoslundia opposita                LF/M      1 
Hoslundia opposita                ST/W      1 
Cymbopogon citratus                 AE/W      1 
Cymbopogon nardus                   AE/M 0.5 1 1   0.5 
Teclea nobilis LF/H  1     
Zanthoxylum chalybeum              LF/W      1 
Zanthoxylum chalybeum              SB/H 0.5     1 
Zanthoxylum chalybeum              SB/W      1 
Zanthoxylum chalybeum              RB/H 1  1   1 
Zanthoxylum chalybeum              RB/M 0.5 0.5 1  1 1 
Lantana trifolia                                  LF/H 0.5 0.5  1   
Lantana trifolia                                  LF/M 0.25 1 0.5 1 1 1 
Lantana trifolia                                  LF/W 1      
Doxycycline  1.56×10-4 3.13×10-4 6.25×10-4 1.56×10-4  3.13×10-4 12.5×10-4 
DMSO 1% (Solvent Control)  - - - - - - 
a Active plant part/E: AE =Aerial part; LF =Leaves; SB=Stem bark; ST= Stem; RT= Root; RB= Root bark; 
H=Hexane extract; M=Methanol extract ; W=Water extract. 
b  Microorganisms: A.a =Aggregatibacter actinomycetemcomitans; P.g = Porphyromonas gingivalis; 
T.f = Tannerella forsythia; S.m= Streptococcus mutans; S.s =Streptococcus sobrinus, L.a= Lactobacillus 
acidophilus 
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4.2 STUDY II 
4.2.1 Essential oil yields  
The essential oils were extracted from 10 aromatic plants and the yields obtained determined. 
The essential oil yields expressed in relation to fresh weight of plant materials (% w/w) are 
presented in Table 4. The yields varied from 0.05% to 0.39%. The highest yield (0.39 % w/w) 
and the lowest (0.05% w/w) were obtained from C. citratus and B. pilosa respectively. 
Table 4. Essential oil yields obtained from the plant species 
Plant species  Essential oil Yield (% w/w) 
Bidens pilosa 0.05 
Helichrysum odoratissimum 0.31 
Vernonia amygdalina N.Da 
Hoslundia opposita 0.12 
Ocimum gratissimum 0.21 
Cymbopogon citratus 0.39 
Cymbopogon nardus 0.36 
Teclea nobilis. Delile 0.16 
Zanthoxylum chalybeum 0.21 
Lantana trifolia 0.14 
aN.D= yield not determined 
 
4.2.2 Chemical composition  
The chemical compositions of the essential oils were analyzed by GC–MS. The compounds 
which were 1% or greater in each oil are presented in Table 5. The minor compounds which 
were which were less than 1% are not presented. The most widely distributed compound was 
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β-Caryophyllene, a sesquiterpenes, which was found in all the oils except that extracted from 
O. gratissimum T. nobilis and Z. chalybeum. 
 
4.2.3 Growth Inhibitory effects of the essential oils 
The essential oils from the ten plants were assessed for their growth inhibitory effects on Gram-
negative periodontopathic bacteria A. actinomycetemcomitans, P. gingivalis and Gram-positive 
cariogenic bacteria S. mutans, L. acidophilus using broth dilution assay. B. megaterium (Gram-
positive) was included in the tests as a reference strain to represent a non-oral pathogenic 
bacterium. The growth inhibitory effects of the oils are presented in Figure 6. Most of the tested 
organisms were sensitive to many of the oils and the chlorhexidine positive control, apart from 
L. acidophilus, whose growth was not significantly inhibited by any of the oils (Figure 6, A 
and B).  However, the growth of  L. acidophilus was  inhibited by the chlorhexidine positive 
control at the three tested concentrations of 1%, 0.2% and 0.05% with p values  of < 0.0001, 
0.0001, 0.0107 respectively (Figure 6 B). The most sensitive organism was A. 
actinomycetemcomitans, as its growth was markedly inhibited by six of the plant oils and the 
chlorhexidine positive controls at all the three concentration tested with p < 0.0001 (Figure 6 
A). This was followed by P. gingivalis, which was markedly inhibited by five of the oils and 
the chlorhexidine control at the three concentrations tested with p < 0.0001(Figure 6 A). 
 
Essential oil from the C. nardus plant exhibited the highest activity with complete growth 
inhibition of the oral pathogens A. actinomycetemcomitans, P. gingivalis and the non-oral 
pathogenic B. megaterium at all the three concentrations tested (Figure 6, A and B). It also 
showed inhibition to the growth of S. mutans at all the three concentrations with p < 0.0001 
(Figure 6 B). 
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Table 5. Chemical composition of the essential oil obtained from the aromatic medicinal 
plants 
 
 Percentage of constituents in essential oila 
Name of constituent [A]b 
B.pic  
[A] 
H.od 
(A) 
V.am 
[L] 
H.op 
[L] 
O.gr 
[P] 
C.ci 
[P] 
C.na 
[(R] 
T.no 
[R] 
Z.ch 
[V] 
L.tr 
Monoterpenes           
3-Carene         8.3  
4-Carene         2.8  
Limonene         2.5  
Myrcene      10.2 10.5    
Cis-β-Ocimene     3.7    2.1  
Trans-β-Ocimene   3.8  7.6   8.5   
α-Phellandrene         5.1  
β-Phellandrene         1.5  
α-Pinene  4.2       1.1  
β-Pinene         2.6 3.0 
Terpinolene         1.4  
Oxygenated Monoterpenes           
Artemiseole      1.6     
1,8-Cineol         1.1  
Citronellal         1.1  
Geranial      35.7   13.3  
Geranic acid      7.2     
Geraniol      3.8   2.4  
Geranyl acetate         1.5  
Linalool 1.4    1.0 1.3   6.4  
Neral      28.6   9.9  
Nerolic acid      2.5     
Terpinene-4-ol         22.3  
α-Terpineol         2.2  
Cis-β- Terpineol,   4.0      1.2 2.4 
Sesquiterpenes           
α-Bulnesene  2.8         
Cadinene 3.8    1.7      
δ-Cadinene  7.0  11.4    7.3   
Calarene       4.6    
β-Caryophyllene 12.6 12.6 5.9 10 3.5  1.0   8.4 
Cedrene 1.5  3.0       3.3 
α-Copaene  7.3  4.6 2.0      
β-cubebene 11.7    10.9      
γ-Elemene       1.6 2.4  1.5 
β-Elemene       1.9    
E,E -α-Farnesene   3.6       4.9 
β-Farnesene     5.5     1.2 
Germacrene D   27.5 28.7   1.3 54.4  23.7 
α-Gurjunene        4.9   
Humulene  14.1  24.4      2.9 
α-Muurolene       4.3    
β-Patchoulene       4    
Selina-3,7(11)-diene  3.3         
Thujopsene 4.6          
Oxygenated Sesquiterpenes           
α-Cadinol 1.3   1.8   2.1 9.1  1.2 
tau.-Cadinol        2.0   
Elemol       1.8    
Eudesmol       1.8    
Germacrene D-4-ol       8.6    
(-)-Globulol 1.0          
Guaiol       1.2    
Intermedeol       43.7    
Ledol     1.2      
Levomenol  7.3         
Nerolidol 1.1  2.4     1.9   
3-Methyl-4-(1,3,3-trimethyl-7-
oxa-bicyclo[4.1.0]hept-2-yl)-
but-3-en-2-one 
      3.4    
Muurolol        3.4   
Diterpene           
Phytol  1.6 2.3 4.3    1.2  5.9 
Aromatic compounds           
Elixene 5.1          
Eugenol   18.3  56.4     3.7 
Methyl isoeugenol        1.7   
Aromatic compound 24.4          
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Table 2 continued 
 
 Percentage of constituents in essential oil 
Name of constituent [A] 
B.pi  
[A] 
H.od 
 
(A) 
V.am 
 
[L] 
H.op 
 
[L] 
O.gr 
 
[P] 
C.ci 
 
[P] 
C.na 
 
[(R] 
T.no 
 
[R] 
Z.ch 
 
[V] 
L.tr 
 
Aliphatic Compounds           
Decanal         1.1  
19,19-Dimethyl-eicosa-8,11-
dienoic acid 
 3.8         
3,4-Dimethyl-1-hexene   2.4       1.1 
Ethyl linolenate  3.9  3.7      18.4 
Methyl linolenate          3.1 
1-Hexanol 2.2          
2-Hexen-1-ol 1.2          
2-Hexenal 1.6          
6-Methyl-3-heptanol          2.7 
6-Methyl-5-hepten-2-one      1.5     
Methyl octadec-9-en-12-ynoate  2.2         
Myristic acid  1.4         
3-Octanol   3.9        
1-Octen-3-ol   13.9  1.1      
Palmitic acid  27.1 5.9 10.2    2.1  11.2 
2-Undecanone      1.1     
Othersd 26.5 1.4 3.1 1.0 5.4 6.5 8.2 1.1 10.1 1.4 
 
a Expressed as percentage of the peak area relative to the total peak area and only constituents which were 1%  
or larger are shown. 
b Plant family names: [A] = Asteraceae; [L] =Lamiaceace; [P] = Poaceae; [R] =Rutaceae; [V] =Verbencaeace. 
c Plant species names: B.pi = Bidens pilosa; H.od= Helichrysum odoratissimum; V.am= Vernonia amygdalina; 
H.op= Hoslundia opposita; O.gr= Ocimum gratissimum; C.ci= Cymbopogon citratus; C.na= Cymbopogon 
nardus; T.no= Teclea nobilis. Delile; Z.ch= Zanthoxylum chalybeum; L.tr= Lantana trifolia 
d Other compounds which  were less than 1% in the oil. 
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Figure 6. Inhibitory effects of plant essential oils on bacterial growth determined by colony forming units 
(CFU) assay. The individual bars show the number of surviving bacteria expressed as a percentage of control 
(n= 4, error bar = S.E.M). Differences in CFU in the control plate and CFU in each tested concentration of the 
oil or chlorhexidine (in the original dataset) statistically analyzed using the Independent Student’s t-test: * = p 
< 0.05 to 0.0001, ** = p < 0.0001 compared with the control. The plant essential oil in-test concentration is in 
percentage of final assay volume. (A) Gram-negative bacteria: A. actinomycetemcomitans, P. gingivalis. (B) 
Gram-positive bacteria: S. mutans, L. acidophilus, B. megaterium. Positive control: CHX= Chlorhexidine. Plant 
species names: B.pi = Bidens pilosa; H.od= Helichrysum odoratissimum; V.am= Vernonia amygdalina; H.op= 
Hoslundia opposita; O.gr= Ocimum gratissimum; C.ci= Cymbopogon citratus; C.na= Cymbopogon nardus; 
T.no= Teclea nobilis. Delile; Z.ch= Zanthoxylum chalybeum; L.tr= Lantana trifolia. Plant family names: (A) = 
Asteraceae; (L) =Lamiaceace; (P) = Poaceae; (R) =Rutaceae; (V) =Verbencaeace 
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4.3 STUDY III 
4.3.1  Cytotoxicity of the essential oils on human gingival fibroblast 
We analyzed the cytotoxicity (IC50 values) of the essential oils from B. pilosa, C. nardus Z. 
chalybeum and O. gratissimum on human gingival fibroblasts presented in Table 6. The IC50 
values differed significantly between the four oils (P=0.0003). Tukeys post hoc comparisons 
test indicated statistically significant differences in mean IC50 values of all the oil except that 
of B. pilosa and O. gratissimum. The essential oil from C. nardus essential oil was the least 
cytotoxic. The overall rating of cytotoxicity was thus Z. chalybeum >O. gratissimum ≥ B. pilosa 
> C. nardus 
 
Table 6. IC50 values of the essential oils on human gingival fibroblasts 
Plant essential oil  Cytotoxicity ( IC50 values in mg/ml) 
Bidens pilosa  0.038 ±  0.007 
Cymbopogon nardus  0.050 ± 0.004 
Ocimum gratissimum  0.036 ± 0.002 
Zanthoxylum chalybeum  0.026 ± 0.003 
 
4.3.2 Effect of essential oils on IL-1β-induced secretion of IL-6, IL-8 and PGE2 in 
human gingival fibroblasts. 
Using human gingival fibroblast cells exposed to IL-1β to provoke an inflammatory response, 
we assessed the effects of essential oils at sub-cytotoxicity concentrations on cytokines and 
chemokine secretion and the results are presented in Figure 7. In the absence of IL-1β (control), 
there was baseline secretion of IL-6, IL-8 and PGE2. Cells exposed to IL-1β (300pg/ml) 
showed, as expected, increased secretion of IL-6, IL-8 and PGE2 compared to unexposed cells 
(Figure 7).  Essential oil from B. pilosa had no effect on both baseline and IL-1β induced 
secretion of IL-6 and IL-8 (Figure 7 A (i) and (ii)). However, the oil increased the secretion of 
PGE2 at baseline, but compared with control the increase was not statistically significant 
(Figure 7 A (iii)).  Essential oils from B. pilosa had synergistic effects with IL-1β on the 
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secretion of PGE2 at concentrations of 20µg/ml (P < 0.05) (Figure 7 A (iii)).  Essential oil from 
C. nardus had no effect on baseline secretion of IL-6, IL-8 and PGE2 (Figure 7 B). However, 
this oil exhibited statistically significant decrease in IL-β induced IL-6 secretion specifically at 
15µg/ml concentrations compared to cells exposed to IL-β alone (Figure 7 B (i)). The oil also 
exhibited a tendency to decrease IL-β induced IL-8 secretion with increasing concentrations 
(7.5, 15, 30µg) by 20%, 21% and 39% respectively, but the decreases were not statistically 
significant (Figure 7 B (ii)). Essential oil from C. nardus, had synergistic effects with IL-1β on 
the secretion of PGE2 specifically at 30µg/ml concentrations (P < 0.05) (Figure 7 B (iii)). 
Essential oil from Z. chalybeum had no effect on baseline secretion of IL-6, IL-8 and PGE2 
(Figure 7 C). Z. chalybeum oil, however, exhibited statistically significant decreased in IL-β 
induced IL-6 secretion specifically at 5µg/ml concentration (P < 0.05) (Figure 7 C (i)). 
Essential oil from O. gratissimum had no effect on baseline secretion of IL-6 and IL-8 (Figure 
7 D (i) and (ii)). The oil, however, decreased baseline secretion of PGE2 with increasing 
concentrations (5, 10, 20 µg/ml) by 23%, 32% and 43% respectively, with statistically 
significant decreases at 10µg/ml and 20µg/ml concentrations compared with the control 
(Figure 7 D (iii)). The oil also significantly decreased IL-β induced PGE2 secretion by 59-63% 
(P < 0.05), but there was no specific dose- response relationship (Figure 7 D (iii)). 
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Figure 7. Effect of essential oils from Ugandan medicinal plants on IL-1β-induced secretion of IL-6, IL-8 and 
PGE2 in human gingival fibroblasts. Human gingival fibroblasts were treated with IL-1β alone (300pg/ml), 
essential oils at increasing sub-cytotoxicity concentrations, or combination of IL-1β (300pg/ml) and essential oils. 
Untreated cells were used as control. IL-6, IL-8, PGE2 secretions was assessed by enzyme-linked immunosorbent 
(ELISA). The data are the means ± standard deviations of triplicate assays for three independent experiments. 
Statistical significance was determined using one-way ANOVA and tukey’s post hoc test. *P < 0.05 compared 
with the untreated control, **P < 0.05 compared with cells stimulated with 300 pg/ml IL-β alone. 
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5 DISCUSSION  
5.1 DISCUSSION OF MAIN FINDINGS  
The major findings in this thesis were that fresh pulp juice from Z. chalybeum and E. latidens 
showed activity against all the bacterial species tested, and at all strengths (Table 2), thus 
confirming that chewing sticks prepared from fresh roots of these plants produce some anti-
bacterial effects on oral bacteria. To the best of our knowledge, this is the first time the anti-
bacterial effects of extracts from E. latidens is being reported.  However, there are also reports 
that fresh root samples from a closely related species, Euclea natalensis, have anti-bacterial 
effects on S. mutans and deep periodontal pocket isolates (Stander and Van Wyk, 1991). The 
Eucela genus is known to contain naphthoquinones (Joubert et al., 2006), which are phenolic 
compounds with significant anti-bacterial properties (Babula et al., 2007). It is therefore 
probable that the activity exhibited by E. latidens in this study is due to the presence of 
naphthoquinones. 
 
This is also the first time anti-bacterial effects is shown on fresh root samples from Z. 
chalybeum (synonyms: Fagara chalybea (Engl.) Engl, Fagara olitoria (Engl.) Engl, Fagara 
fischeri Engl.). Most studies on anti-bacterial effects of Z. chalybeum (Matu and van Staden, 
2003; Olila et al., 2001) or closely related species (Wolinsky and Sote, 1983) have used 
solvent extracts prepared from dried plant materials or different bacterial species, thus 
making comparisons with this finding difficult. The genus Zanthoxylum are deciduous shrubs 
and trees, comprising of more than 200 species that are widely distributed, mainly in the 
temperate and tropical regions (Negi et al., 2011). Many of the species in this genus are rich 
in alkaloids, especially the benzophenanthridine alkaloids, which are compounds with 
diverse biological activities, including anti-microbial (Ming Ng et al., 1987; Patiño et al., 
2012). The activity of the Z. chalybeum species observed in this study could probably also 
be attributed to alkaloids. 
 
The fact that fresh pulp juice from Z. chalybeum and E. latidens were active at 50% and 25% 
strength is significant. The roots from these two plants are used as chewing sticks for brushing 
teeth and during normal use, the extracts or juices produced are subjected to the diluting 
action of saliva. So, the 50 % and 25% strengths of fresh pulp juice tested was an attempt to 
approximately mimic the conditions in the mouth after a reasonable period of exposure. It 
can therefore be argued that, in addition to mechanical effects, there are also associated anti-
bacterial activities which should reduce the cariogenic and periodontopathic bacterial load in 
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the mouth. However, clinical studies are still warranted to determine whether the extracts kill 
bacteria in vivo. 
 
We had rationalized that demonstration of anti-bacterial effects of fresh extracts from some 
plants against bacteria associated with dental caries and periodontal diseases would promote 
the use of these plants as cheap alternative to western toothbrush/toothpaste. In this study, 
anti-bacterial effects of fresh Z. chalybeum and E. latidens were demonstrated in the roots. 
As common in most communities, medicinal plants are usually not cultivated, but harvested 
from the wild. (Zschocke et al., 2000). Harvesting of plant roots, if not controlled can easily 
led to extinction of plant species. It is therefore absolutely important that any future 
promotion of the use of these plants for oral health care should be accompanied by sustainable 
harvesting strategies. 
 
We also demonstrated anti-bacterial effects on some solvent extracts prepared from dry plant 
materials. The important finding was that hexane extract from the aerial part of H. 
odoratissimum exhibited good anti-bacterial effects on all the bacterial species tested (MIC 
0.0125 to 0.5 mg/ml) except A. actinomycetemcomitans (Table 3). This the first report on 
anti-bacterial effects of hexane extract from this plant species. Previous studies had work on 
the methanol extract and isolated 3-O-Methylquercetin as an active principle with anti-
microbial activity (Van Puyvelde et al., 1989).  The low MIC demonstrated by the hexane 
extract on several bacterial species is a clear indication that the extract has very potent active 
principles which could be of importance in the treatment or prevention of dental infections 
caused by these bacterial species.  
 
We found that methanol extract from the leaves L. trifolia was active on all bacterial species 
tested with MIC ranging from 0.25 to 1 mg/ml (Table 3). Previously studies also reported 
anti-microbial activity from this extract and the compound Umuhengerin was isolated as the 
active principles (Rwangabo et al., 1988). Umuhengerin was found to have activity on several 
microorganisms including Staphylococcus aureus, Salmonella typhimurium, Candida 
tropicalis, Aspergillus niger, Aspergillus fumigatus and Trichophyton mentagrophytes 
(Rwangabo et al., 1988). The concentration of active principles in the leaves is particularly 
important for sustainability of the species (Zschocke et al., 2000). 
 
Other solvent extracts which showed activity on at least 3 or more bacterial species were 
methanol extract from aerial part of H. odoratissimum, methanol extract from aerial part of 
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C. nardus, methanol and hexane extracts from root bark of Z. chalybeum and hexane extract 
from the leaves of L. trifolia. Generally, we found more activities in the methanol extracts 
that in the water or hexane extracts. This is probably because methanol is a solvent with 
amphiphilic characteristics and can therefore dissolve both polar and non-polar molecules. 
The larger the variety of compounds that are extracted by the solvent, the better the chance 
to extract biologically active components (Eloff, 1998) 
 
In this thesis, essential oils from the aromatics medicinal plants were also investigated for 
their inhibitory effects on the cariogenic S. mutans, L. acidophilus and periodontopathic P. 
gingivalis, and A. actinomycetemcomitans. As a first step towards assessing their potential 
use, we measured the essential oil yields from the plants at the time of extraction. 
Ascertaining essential oil yield is significant because not all plants produce enough essential 
oil to justify future research efforts and/or commercialization. In our study, the lowest oil 
yield was obtained from B. pilosa (0.05%) and the highest from the two Cymbopogon species, 
namely C. nardus (0.36% w/w) and C. citratus (0.39 % w/w). Other reports have confirmed 
the Cymbopogon species to produce high amount of essential oils, though the yields are 
usually affected by external factors like geographical location, climate, nature of the soil, age 
of the plant, time of collection and mode of extraction oil (Akhila, 2009). 
 
Besides the high yield, C. nardus essential oil also exhibited the highest activity with 
complete growth inhibition of periodontopathic bacteria P. gingivalis and A. 
actinomycetemcomitans at all the three concentrations tested (Figure 6 A). It also showed 
inhibition to the growth of S. mutans at all the three concentrations with p < 0.0001 (Figure 
6 B).  Previous reports described essential oil from C. nardus to be bactericidal to the human 
pathogens Escherichia coli strain NCTC 10418, and Staphylococcus aureus, though at a 
concentration of 0.25 % (v/v) (Hammer et al., 1999). GC-MS analysis revealed the major 
constituents in C. nardus oil to be dominated by oxygenated sesquiterpenes, specifically 
intermedeol (Table 5). In a separate bioassay-guided fractionation experiment using a non-
oral bacteria Bacillus subtilis, we confirmed the compound intermedeol as one of the 
bioactive molecules in this essential oil (Toom, 2014). However, the activity of intermedeol 
on oral bacteria is yet to be established.   
 
Other essential oils which were considered promising were those which markedly inhibited 
growth of at least two bacteria at all the three concentrations tested with p < 0.0001 and these 
oils were from the following plants species: T. nobilis, H. opposita, O. gratissimum, and B. 
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pilosa. Generally, the essential oils in this study showed marked growth inhibitory effects on 
the Gram-negative periodontopathic bacteria A. actinomycetemcomitans and P. gingivalis 
than the Gram- positive cariogenic bacteria S. mutans and L. acidophilus. This findings is in 
line with another study that found essential oil from Salvodra persica to have high killing 
activity against Gram-negative periodontopathic bacteria A. actinomycetemcomitans and P. 
gingivalis and less activity on Gram- positive cariogenic bacteria S. mutans and L. 
acidophilus (Sofrata et al., 2011). However, the finding is contrary to reports that Gram-
negative bacteria are less susceptible to anti-bacterial agents due to the presence of an outer 
membrane surrounding their cell walls which restrict diffusion of hydrophobic compounds 
through lipopolysaccharide covering (Nazzaro et al., 2013). The sensitivity of Gram-negative 
bacteria to the essential oils has been suggested to be due to the presence of some individual 
components in the oil which has both lipophilic as well as electrophilic properties and this 
enable them to penetrate through the outer bacterial membrane (Sofrata et al., 2011).  
 
The marked growth inhibitory effects of most of these essential oils on Gram-negative 
periodontopathic bacteria A. actinomycetemcomitans and P. gingivalis suggest the oils could 
be worth exploring for possible application in treatment of periodontal diseases. The tissue 
degrading inflammation that destroy periodontal tissues in individuals susceptible to 
periodontitis is known to be initiated by these specific Gram-negative bacteria (Yucel-
Lindberg and Bage, 2013). It has thus been suggested that a treatment approach that can 
directly control the bacterial infection and at the same time modulate the inflammatory 
response would be a better option in the management of periodontitis (Tonetti and Chapple, 
2011). On this basis, we investigated the anti-inflammatory potentials of essential oils that 
had shown promising anti-bacterial effects on the Gram-negative periodontopathic bacteria. 
The essential oils were investigated for their ability to reduce production of pro-inflammatory 
cytokines (IL-6, IL-8 and prostaglandin E2) by human gingival fibroblasts. An important 
finding was that essential oil from O. gratissimum significantly decreased induced and 
baseline secretion of PGE2 (Figure 7 D (iii)), suggesting possible application of this oil in 
treatment of periodontitis. 
 
The synthesis of PGE2 is regulated via 3 groups of enzymes, namely, phospholipase A2, 
cyclooxygenase (COX), and prostaglandin E synthase (PGES). The phospholipase A2 
enzymes catalyze the conversion of membrane lipids to arachidonic acid, which is further 
converted to prostaglandin H2 (PGH2) by the two COX isoforms (COX-1 and COX-2). COX-
1 is responsible for the baseline levels of PGE2 while COX-2 produces induced PGE2. The 
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terminal step from PGH2 to PGE2 is catalyzed by PGES enzymes (Noguchi and Ishikawa, 
2007). Our findings that O. gratissimum essential oil decreased both baseline and induced 
PGE2 secretions suggest that the oil acts upstream by inhibition of either the phospholipase 
A2 or the COX enzymes function. We had shown in Study II that O. gratissimum essential 
oil contain several compounds, the major ones being eugenol (56.4%), and 𝛽-Cubebene 
(10.9%). The compound eugenol had been shown to inhibit arachidonic acid metabolism in 
platelets via the cyclooxygenase pathway (Saeed et al., 1995).  It is therefore probable that 
the observed effect of O. gratissimum essential oil on both the basal and induced PGE2 
secretions could partly be due to the major compound eugenol found in this oil. The analgesic 
property of eugenol has also been attributed to its ability to inhibit PGE2 synthesis (Thompson 
and Eling, 1989). In Uganda, fresh leaves from O. gratissimum is traditionally used in the 
treatment of toothache (Table 1). Our findings that the oil extracted from the leaves of O. 
gratissimum was able to reduce basal and induced PGE2 in gingival fibroblast cells may lend 
credence to the traditional use of the plant in treatment of toothache. 
 
Besides their effects on the production of pro-inflammatory cytokines, the cytotoxicity of the 
four promising essential oils on the human gingival fibroblasts was also important 
consideration in this thesis. Using the IC50 values (Table 6), we rated the cytotoxicity of the 
essential oils from the plants as Z. chalybeum > O. gratissimum ≥ B. pilosa > C. nardus. The 
oil from C. nardus was the least cytotoxic (IC50 =0.050 mg/ml) because more of this oil was 
required to kill a given number of cells compared to other oils. In study II, we established the 
compound Intermedeol as a major component in the C. nardus essential oil. It is not clear 
whether the cytotoxicity of the C. nardus essential oil is due to this major component, 
however, studies have looked at the cytotoxicity of intermedeol on different cell lines and 
found the IC50 values to range from 0.012 mg/ml to 0.077 mg/ml. Future studies of the 
individual isolated major components found in C. nardus oil should include the effects of 
these components on human gingival fibroblast in order to get more insights into their 
toxicities. 
 
Essential oils are complex mixtures of different molecules and each oil may contain between 
20 and 70 components which are usually of low molecular weights and at different 
concentrations. Most molecules are present in traces, while two to three are often the most 
representative components, accounting for 20–70% of the whole oils. The components, 
including the traces, have their specific roles in the oil. Some components may be present to 
neutralize the toxic effects of other components. It is therefore not surprising that some oil 
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components when isolated become more toxic (Bakkali et al., 2008). Some of the oil 
components have been suggested to be responsible for causing allergic reactions in some 
individuals (Aberer, 2008; Ventura et al., 2006). There are reports that these allergic reactions 
are mostly due to the sesquiterpnoid fractions in the oil which occur as a result oxidation of 
aged or improperly stored oil (Hammer et al., 2006; Mitchell et al., 1972). However, the 
reactions are known to occur to a very limited fractions of the human populations and can be 
minimized by avoiding formation of oxidation products in the oil through proper storage 
(Hammer et al., 2006).  
 
In summary, the major findings as outlined in this thesis give insights into the efficacy and 
safety of extracts from the Ugandan medicinal plants in the treatment of periodontal diseases 
and dental caries. With the tremendous increase in interest in the use of natural plant-based 
remedies worldwide, the findings should encourage more research work geared towards 
value-addition and commercialization of the promising plants extracts. Some of these 
endeavors may include isolation and characterization of the active principles in the extracts, 
more toxicological studies and development of products for clinical trials. The potential 
socio-economic contribution of these medicinal plants, in long-term, could be enormous. 
This is especially because some of the plants which have exhibited promising anti-bacterial 
and/or anti-inflammatory effects like H. odoratissimum, C. nardus and O. gratissimum are 
road-side plants and are currently regarded as weeds in the plantation gardens, with little or 
no value attached to them. With value-addition and commercialization, these plants could 
turn into cash crops, thus creating opportunities for employment and wealth creation.  
 
5.2 METHODOLOGICAL CONSIDERATIONS 
5.2.1 Study 1 and II 
In study I and II, all appropriate measures were taken to ensure that the aims for which the 
studies were conducted were achieved. During literature search, only plants that had both 
their local and scientific names mentioned in literature were picked for the study. During 
collection, all possible efforts were made to ensure that the plants were collected from exact 
districts in Uganda where they are being used, as mentioned in the literature. If there was 
need for additional plant materials during the experiments, all efforts were again made to 
collect the particular plant from the exact area where it was first collected. Voucher 
specimens were archived for future follow-up. 
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We also made efforts to test the plant extracts using the recommended methods, and these 
were the agar dilution assay (for solvent extracts) and broth dilution assay (for essential oils) 
(Rios et al., 1988). There is no recommended method for testing anti-bacterial activity in 
fresh pulp juice, so we utilized the agar well-diffusion assay. The agar well-diffusion assay 
was used, in this case, because of its simplicity and capacity to analyze samples quickly and 
cheaply.  However, the method has limitations in that it can only detect activity of substances 
that can easily diffuse into the agar media (Barry, 1986). Thus, it is possible that active 
lipophilic substances in the fresh pulp juice that could not diffuse into the agar media were 
not detected. This could have impacted on the number of active extracts from the fresh plants 
observed in this study. Future methodological studies to determine appropriate method for 
anti-bacterial activity testing in fresh pulp juice could be considered. 
 
In both study I and II, the anti-bacterial effects of the plant extracts were investigated on 
planktonic bacteria. However, the periodontopathic and cariogenic bacteria are clinically 
present in the oral cavity as a biofilm. Recent understandings of biofilm characteristics reveal 
that bacteria living in the biofilm are naturally tolerant to anti-bacterial agents than the 
planktonic counterparts (Sbordone and Bortolaia, 2003). The anti-bacterial effects of the 
plant extracts on the planktonic bacteria observed in this study may therefore not exactly 
reflect their effects in vivo. Future studies on the effects of these extracts on the bacteria in 
their natural ecosystem could be considered. 
5.2.2 Study III 
In selecting plants for study III, considerations were given to ease of availability of the species 
and the plant family. For instance, in Study II, essential oil from the plant T. nobilis (Family: 
Rutaceae family) had shown marked growth inhibitory effects on the Gram-negative bacteria 
and should have been therefore considered for further analysis in Study III.  However, this plant 
species seem to be getting extinct and it is extremely difficult to get. In this respect, we replaced 
the plant T. nobilis with Z. chalybeum, another member of the Rutaceae family, which had also 
shown good growth inhibitory effects on the Gram-negative bacteria, and is readily available. 
Similarly, H. opposita, and O. gratissimum are all from the Lamiaceace family and all of them 
had demonstrated marked growth inhibitory effects on the Gram-negative bacteria. However, 
O. gratissimum is readily available, thus it was picked for further analysis in study III. 
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In study III, in vitro cytotoxicity testing of the essential oils were done on the host cells as 
recommended by the International Organization for Standardization (ISO, 2009) and other 
authors (Cos et al., 2006). The cells in the oral cavity that may come into direct contact with 
the plant essential oils during use are the barrier epithelial cells and the extracellular 
matrix/collagen synthesizing fibroblast cells. Both the epithelial and the fibroblast cells also 
acts as accessory immunes cells and therefore do participate in the local inflammations via their 
productions of cytokines (Takashiba et al., 2003). Both cells type were thus appropriate for 
anti-inflammatory and cytotoxicity testing. In this study, we chose to use primary human 
gingival fibroblasts, grown as monolayer cultures in cell culture flasks. Gingival fibroblast 
monolayer cultures is a useful model that substituted for the real live tissues of the oral cavity 
in our situation. However, cells in the culture system are restricted in growth to a two-
dimensional carrier and are not surrounded by a morphologic organized extracellular 
matrix/collagen and other interacting cells types as seen in real live tissues (Hillmann et al., 
1999). As a result, these cells tend to be more sensitive to drugs or other stimuli than cells in 
vivo. The effects of chlorhexidine digluconate on human gingival fibroblasts is a classic 
example. Chlorhexidine is a widely used mouth-rinse solutions. However, studies have shown 
that the concentrations of chlorhexidine which are highly cytotoxic in vitro generally do not 
harm cells in vivo (Pucher and Daniel, 1993). It is therefore possible that the cytotoxic effects 
of the essential oil extracts on human fibroblasts observed in this study may not truly reflect 
the in vivo situations, given the fact that some of these plants have been used traditionally for 
hundreds of years without documented adverse effects. 
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6 CONCLUSION  
 Besides the mechanical effects, there is also anti-bacterial effects that is assocaited 
with brushing teeth with chewing stickss prepared from fresh roots of  Z. chalybeum 
and E. latidens. However, further clinical studies are warranted to determine the 
effects of chewing sticks prepared from these two plants in vivo. 
 
 The hexane extract from the aerial part of H. odoratissimum has very potent active 
principles that could be of importance in the treatment or prevention of dental caries 
and periodontal diseases. Other solvent extracts that demonstrated good activty and 
thus warranting further investigations are: methanol extract from aerial part of H. 
odoratissimum; methanol extract from aerial part of C. nardus; methanol and hexane 
extracts from root bark of Z. chalybeum; hexane extract from the leaves of L. trifolia.  
 
 The essential oils from the following plants showed marked growht inhibitoy effects 
on at least two bacterial species and are thus considered promising: C. nardus,  T. 
nobilis, H. opposita, O. gratissimum, and B. pilosa. Their marked growth inhibitory 
on  esspecially on Gram-negative periodontopathic A. actinomycetemcomitans and P. 
gingivalis suggest the oils could be worth exploring for possible application in 
treatment of periodontal diseases. 
 
 The essential oils from the test plants showed cytotoxicity to human gingival 
fibroblasts cells, with oil from Z. chalybeum being the most cytotoxic and oil from C. 
nardus the least cytotoxic. The overall rating of cytotoxicity of the essential oil from 
the tested plants was thus Z. chalybeum > O. gratissimum ≥ B. pilosa > C. nardus.  
 
 Essential oil extracted O. gratissimum demonstrated both anti-bacterial and anti-
inflamatory effects suggesting the oil worth exploring for possible application in 
treatmnt of periodontitis.  
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7 FUTURE PERSPECTIVES  
Clinical studies are warranted to determine the in vivo anti-bacterial effects of fresh extracts 
from roots of Z. chalybeum and E. latidens. 
 
The strong anti-bacterial effects of the hexane extract from the aerial part of H. 
odoratissimum against cariogenic and periodontopathic bacteria calls for further studies to 
isolate and identify the active principles in this extract. Other extracts needing further studies 
to isolate and identify their active principles are: methanol extract from aerial part of C. 
nardus; Hexane extract from the leaves of L. trifolia. 
 
Further anti-bacterial and cytotoxicity studies on the individual major components of the 
promising essential oils to explore if the components can be used alone or in combination 
with other components. Further studies should also explore combination of different essential 
oils to see if there is considerable enhancement of anti-bacterial effects compared to 
individual oils  
 
Further studies on the cytotoxic effects of the promising essential oils on keratinocytes. 
 
The possibility of a natural products with has both anti-bacterial and anti-inflammatory 
effects is promising. Further studies should look into developing the oil from O. gratissimum 
into some products and testing the anti-bacterial and anti-inflammatory effects in vivo. 
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